Table 4.
Treatment received by patients hospitalized with COVID-19 at the University College Hospital, Ibadan
| Treatments | Overall n (%) |
Dead | Alive | Chi square |
P value |
| Chloroquine and/or hydroxychloroquine |
8(9.3) | 4 (50.0) | 4 (50.0) | 0.019 | 0.890 |
| Dexamethasone | 42(48.8) | 11 (26.2) | 31 (73.8) | 15.189 | <0.001 |
| Enoxaparin | 64(74.4) | 26 (40.6) | 38 (59.3) | 4.984 | 0.026 |
| Angiotensin Converting Enzyme Inhibitor |
20(23.3) | 5 (25.0) | 15 (75.0) | 5.371 | 0.020 |
| Zinc | 54(62.8) | 17 (31.5) | 37 (68.5) | 15.254 | <0.001 |
| Vitamin C | 57(66.3) | 19 (33.3) | 31(73.8) | 15.189 | <0.001 |
| Vitamin D | 51(59.3%) | 16(31.4) | 35(68.6) | 13.350 | <0.001 |
| Ceftriaxone | 63(73.3%) | 28(44.5) | 35(55.6) | 0.985 | 0.321 |
| Azithromycin | 57(66.3) | 21(36.8) | 36(63.2) | 7.951 | 0.005 |